The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Geron Corporation (GERN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.01, or 0.41%, to $2.44. The Geron Corporation has recorded 144,987 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Geron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDS.
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $2.43 and fluctuated between $2.4500 as its day high and $2.3400 as its day low. The current market capitalization of Geron Corporation is $1.19B. A total of 6.21 million shares were traded on the day, compared to an average of 5.61M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, GERN has seen 3 BUY and 0 SELL insider trades, representing the acquisition of 13,894 and the disposition of 0 shares. Over the last 12 months, there were 18 BUYs and 8 SELLs from insiders. Insiders purchased 2,265,035 shares during that period but sold 2,194,719.
In the most recent transaction, O’Farrell Elizabeth G. bought 6,607 shares of GERN for 2.28 per share on Aug 24. After the transaction, the Director now owns 7,407 company shares. In a previous transaction on Aug 24, O’Farrell Elizabeth G. bought 6,579 shares at 2.28 per share. GERN shares that Director owns now total 26,220.
Among the insiders who sold shares, LAWLIS V BRYAN disposed of 35,000 shares on May 11 at a per-share price of $3.00. This resulted in the Director holding 0 shares of GERN after the transaction. In another insider transaction, Molineaux Susan sold 35,000 shares at $2.48 per share on May 01. Company shares held by the Director now total 0.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for GERN in the last 3 months, the mean price target is $4.83 with high estimates of $6.00 and low estimates of $4.00. In terms of 52-week highs and lows, GERN has a high of $3.84 and a low of $1.95.
As of this writing, GERN has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.09 per share and a lower estimate of -$0.12. The company reported an EPS of -$0.07 in the last quarter, which was 30.00% higher than expectations of -$0.1.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GERN’s latest balance sheet shows that the firm has $183.72M in Cash & Short Term Investments as of fiscal 2021. There were $55.00M in debt and $45.52M in liabilities at the time. Its Book Value Per Share was $0.55, while its Total Shareholder’s Equity was $126.42M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GERN is Buy with a score of 4.40.